American Association for the Advancement of Science, Science Translational Medicine, 480(11), 2019
DOI: 10.1126/scitranslmed.aat2189
Full text: Unavailable
Clinical trials of mesenchymal stromal cell therapies reveal a challenging heterogeneous landscape, including diverse therapeutic targets, patient categories, cell sources, and potential mechanisms of action.